What is the recommended treatment plan for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Plan for H. pylori Infection

Bismuth quadruple therapy for 14 days is the preferred first-line treatment regimen for H. pylori infection when antibiotic susceptibility is unknown, with an eradication rate of approximately 85%. 1

First-Line Treatment Options

Preferred First-Line Treatment:

  • Bismuth quadruple therapy (14 days) 1
    • Components typically include:
      • Proton pump inhibitor (PPI) standard dose twice daily
      • Bismuth subsalicylate/subcitrate
      • Tetracycline
      • Metronidazole

Alternative First-Line Options:

  1. Concomitant non-bismuth quadruple therapy (14 days) - approximately 80% eradication rate 1

    • PPI + amoxicillin + clarithromycin + metronidazole
  2. Triple therapy (14 days) - may be used in areas with low clarithromycin resistance 1

    • PPI + amoxicillin (1g twice daily) + clarithromycin (500mg twice daily) 2

Second-Line Treatment Options

If first-line therapy fails, second-line treatment should avoid previously used antibiotics 1:

  • After bismuth quadruple therapy failure:

    • Levofloxacin-based triple therapy for 10-14 days 1, 3
  • After clarithromycin-based therapy failure:

    • Bismuth quadruple therapy for 14 days 1, 4

Third-Line Treatment Options

For patients who have failed two previous treatment attempts:

  • Rifabutin-based triple therapy (10 days) 1, 5

    • Rifabutin 150-300mg daily
    • Amoxicillin 1g twice daily
    • PPI standard dose twice daily
  • High-dose dual therapy (14 days) 1, 6

    • Amoxicillin 2-3g daily in 3-4 split doses
    • PPI high-dose twice daily

Diagnostic Testing

  • Before treatment: 13C urea breath test or monoclonal stool antigen test (sensitivity and specificity >90%) 1
  • Post-treatment confirmation: Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1

Special Considerations

Penicillin Allergy

  • For patients with true penicillin allergy, use bismuth quadruple therapy with tetracycline instead of amoxicillin 1
  • PPI-tetracycline-metronidazole is an effective alternative 1

Antibiotic Resistance

  • Increasing resistance to clarithromycin, levofloxacin, and metronidazole is a major cause of treatment failure 1, 6
  • Previously used antibiotics should be avoided in subsequent eradication attempts 1
  • Local antibiotic resistance patterns should guide therapy selection when available 1, 5

Dietary and Lifestyle Management

  • Diet low in acidic, spicy, and fatty foods is recommended 1
  • Regular consumption of fruits and vegetables rich in vitamin C 1
  • Eating smaller, more frequent meals and avoiding eating within 3 hours of bedtime 1
  • Staying hydrated with water throughout the day 1

Treatment Administration Guidelines

  • Amoxicillin should be taken at the start of a meal to minimize gastrointestinal intolerance 2
  • Treatment should be continued for the full prescribed duration to ensure complete eradication 2
  • Patients with severe renal impairment (GFR <30 mL/min) require dosage adjustments 2

Monitoring and Follow-up

  • Confirm eradication with urea breath test or stool antigen test 4-8 weeks after therapy completion 1, 3
  • Surveillance endoscopy should be performed every 3 years in patients with risk factors for gastric cancer or atrophic gastritis 1
  • Patients aged ≥55 or with alarm symptoms should be referred for prompt endoscopy with H. pylori testing 1

The increasing prevalence of antibiotic resistance highlights the importance of following evidence-based treatment regimens and confirming eradication after treatment completion. Bismuth-containing regimens have become increasingly important as first-line therapy due to their effectiveness against resistant strains 1, 5.

References

Guideline

Treatment of Patients with Helicobacter pylori Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2017

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.